Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 6, 1998, Pages 491-496

  Raaphorst, G P ^a   Miao, J ^a   Stewart, D ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin; Combined treatment; Hyperthermia; Ovarian carcinoma; Radiation

Indexed keywords

CISPLATIN;

ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CELL REGENERATION; CELL SUBPOPULATION; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; HYPERTHERMIA; IRRADIATION; OVARY CARCINOMA; PRIORITY JOURNAL; RADIATION INJURY; RADIOSENSITIZATION;

ANIMALS; CELL SURVIVAL; CISPLATIN; COMBINED MODALITY THERAPY; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; OVARIAN NEOPLASMS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED; X-RAYS;

EID: 0031886075     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050772     Document Type: Article

References (54)

1. Begg AC (1990) Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int J Radiat Oncol 19: 1183-1189
2. Begg AC, Van Der Kolk PJ, Dewit L, Bartelink H (1986) Radio-sensitization by cisplatin of RIF1 tumour cells in vitro. Int J Radiat Oncol 50: 871-884
3. Berger NA, Kurohara KK, Pelzold SJ (1979) Aphidicolin inhibits eukaryotic DNA replication and repair, implications for involvement of DNA polymerase a in both processes. Biochem Biophysics Res Commun 89: 218-225
4. Bosscha HT, Timmer A, Meijer C, et al (1993) Cis-diaminedichloroplatin (II) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res 53: 5707-5713
5. Canon JL, Humblet Y, Symann M (1990) Resistance to cisplatin: how to deal with the problem? Eur J Cancer 26: 1-3
6. Carde P, Lavai F (1981) Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. Int J Radiat Oncol 7: 929-933
7. Coughlin CT, Richmond RC (1985) Platinum based combined modality approach for locally advanced head and neck carcinoma. Int J Radiat Oncol 115: 915-919
8. Dewit L (1987) Combined treatment of radiation and cis-diaminedichloroplatinum (II): a review of experimental and clinical data. Int J Radiat Oncol 13: 403-426
9. Dewit L, Bartelink H, Rumke PH (1985) Concurrent cis-diamminedichloroplatinum(II) and radiation treatment for melanoma metastases: a pilot study. Radiother Oncol 3: 303-309
10. Douple EB (1990) Interaction between cisplatin coordination complexes and radiation. In: Hill BT, Bellamy AS (eds) Antitumour drug-radiation interactions. CRC Press, Boca Raton, pp 171-190
11. Dritschilo A, Piro A, Kelman AD (1979) The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. Int J Radiat Oncol 5: 1345-1349
12. Eastman A, Schulte N (1988) Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum (II). Biochemistry 27: 4730-4734
13. Elkind MM, Sutton H (1960) Radiation response of mammalian cells grown in culture. 1 Repair of x-ray damage in surviving Chinese hamster cells. Rad Res 13: 556-593
14. Fujii R, Mutak M, Niwa K, et al (1994) Active efflux for cisplatin in cisplatin-resistant human KB cells. Jpn J Cancer Res 85: 426-433
15. Hamilton TC, Lai GM, Rothenberg LM, et al (1989) Mechanisms of resistance to cisplatin and alkylating agents. In: Ozols RF (ed) Drug Resistance in cancer therapy. Kluwer Academic Publishers, Boston, pp 151-169
16. Herman TS, Teicher BA (1988) Sequencing of trimodality therapy (cis-diamminedichloroplatinum (II)/hyperthermia/radiation) as determined by tumour growth delay and tumour cell survival in the FSaIIC fibrosarcoma. Cancer Res 48: 2693-2697
17. Herman TS, Teicher BA, Holden SA, Pfeffer MR, Jones SM (1990) Addition of 2 nitroimidazole radiosensitizers to cis-diamminedichloroplatinum (II) with radiation and with or without hyperthermia in the murine FSaIIC. Cancer Res 50: 2734-2740
18. Ireland CM, Pittman SM, Jones SL, Harnett PR (1994) Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines. Anticancer Res 14: 2397-2404
19. Jekunen AP, Hom DK, Alcaraz JE, Eastman A, Howell SB (1994) Cellular pharmacology of dichloro(ethylenediamine) platin II in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Res 54: 2680-2687
20. 1 or late S phase. Cancer Res 53: 1239-1243
21. Kuske RR, Perez CA, Grigsby PW, et al (1989) Phase I/II Study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Am J Clin Oncol 12: 467-473
22. Little JB (1969) Repair of sublethal and potentially lethal radiation damage in plateau cultures of human cells. Nature 224: 804-806
23. Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M, Hamilton TC (1988) Increased DNA repair as a mechanism of acquired resistance to cis-diaminedichloroplatinum II in human ovarian cancer cell liens. Cancer Res 48: 5713-5716
24. Meijer C, Mulder NH, Hospers GAP, Uges DRA, Vries EGE de (1990) The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 62: 72-77
25. Micetich K, Zwelling L, Kohn KW (1983) Quenching of DNA: platinum (II) monoadducts as a possible mechanism of resistance to cis-diaminedichloroplatinum (II) in L1210 cells. Cancer Res 43: 3609-3613
26. Nakatsugawa S, Kada T, Nikaido O, Tanaka Y, Sugahara T (1984) PLDR inhibitors. Their biological and clinical implications. Br J Cancer 49: 43-47
27. Nias AHW (1985) Radiation and platinum drug interaction Int J Radiat Biol 48: 297-314
28. Philips RA, Tolmach LJ (1966) Repair of potentially lethal damage in x-irradiated Hela cells. Radiat Res 29: 413-432
29. Piver MS (1984) Ovarian carcinoma, a decade of progress. Cancer 54: 2706-2715
30. Raaphorst GP (1992) Recovery of sublethal radiation damage and its inhibition by hyperthermia in normal and transformed mouse cells. Int J Radiat Oncol 22: 1035-1041
31. Raaphorst GP, Dewey WC (1979a) A study of the repair of potentially lethal damage and sublethal radiation damage in Chinese hamster cells exposed to extremely hypo-and hypertonic NaCl solutions. Radiat Res 77: 325-340
32. Raaphorst GP, Dewey WC (1979b) Fixation of potentially lethal radiation damage by post-irradiation exposure of Chinese hamster cells to 005 M or 15M NaCl solutions. Int J Rad Biol 36: 303-315
33. Raaphorst GP, Fecley MM (1994) Comparison of post hyperthermia radiosensitivity for survival, PLDR and polymerase activity in human glioma cells. Int J Radiat Oncol 29: 133-139
34. Raaphorst GP, Freeman ML, Dewey WC (1979) Radiosensitivity and recovery from radiation damage in cultured CHO cells exposed to hyperthermia at 425 and 455 °C. Radiat Res 79: 390-402
35. Raaphorst GP, Mao JP, Ng CE (1993) Repair of potentially lethal damage: its inhibition by hyperthermia in two melanoma cell lines with different radio-and heat sensitivities. Melanoma Res 3: 351-356
36. Raaphorst GP, Mao JP, Ng CE (1994) Sublethal radiation damage repair and its inhibition by hyperthermia in two human melanoma cell lines of different radiosensitivity. Melanoma Res 4: 157-161
37. Raaphorst GP, Yang DP, Grewaal D, Stewart D, Goel R, Ng CE (1995a) Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncol Rep 2: 1037-1043
38. Raaphorst GP, Wang G, Ng CE (1995b) Radiosensitization by cisplatin treatment in cisplatin resistant and sensitive human ovarian carcinoma cell lines. Int J Oncol 7: 325-330
39. Raaphorst GP, Wang G, Stewart D, Ng CE (1995c) A study of cisplatin-radiosensitization through inhibition of repair of sublethal radiation damage in ovarian carcinoma cells sensitive and resistant to cisplatin. Int J Oncol 7: 1373-1378
40. Raaphorst GP, Wang G, Stewart D, Ng CE (1996a) Concomitant low dose rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. Int J Radiol Biol 69: 623-631
41. Raaphorst GP, Chabot P, Doja S, et al (1996b) Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. Int J Hypertherm 12(2): 211-222
42. Schwachofer JHM, Crooijmans RPMA, Hoogenhout J, Kal HB, Theeuwes AGM (1991) Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol 20: 1235-1241
43. Sledge GW (1992) Cisplatin and platinum analogues in breast cancer. Semin Oncol 19: 78-82
44. Spadari S, Pedrali-Noy G, Focher F, et al (1986) DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs. Anticancer Res 6: 935-940
45. Sugahara T, Nakatsugawa S, Nikaido O (1984) PLD repair inhibitors as radiosensitizers. Radiat Phys Chem 24: 321-328
46. Szumiel I, Nias AHW (1976) The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. Br J Cancer 33: 450-458
47. Taylor SG, Murphy AK, Vannetzel JM, et al (1994) Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12: 385-395
48. Wallner KE, Li GC (1987) Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol 13: 587-591
49. Walter P, Korbelik M, Spadinger I, Skov K (1993) Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (2 Gy) doses in hypoxic cells: Role of single strand breaks. Radiat Oncol Invest 1: 137-147
50. Ward JF (1986) Mechanisms of DNA repair and their potential modification for radiotherapy. Int J Radiat Oncol 12: 1027-1032
51. Whitmore GF, Culyas S (1967) Studies on recovery processes in mouse L cells. Natl Cancer Inst Monogr 24: 141-153
52. Wilkins DE, Heller DP, Raaphorst GP (1993) Inhibition of potentially lethal damage recovery by cisplatin in a brain tumour cell line. Anticancer Res 13: 2137-2142
53. Wurschmidt F (1992) Combined modality treatment of the rhabdomyosarcoma RIH of the rat: influence of sequence of cisplatin and fractionated irradiation. Int J Radiat Oncol 25: 73-78
54. Zietman AL, Shipley WU, Kaufman DS (1993) The combination of cisplatin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int J Radiat Oncol 27: 161-170